Skip to main content
ARNAinactive

ARENA PHARMACEUTICALS INC

Biopharma developer (SEC filing verified)·Phase 3·CEO: Arena Pharmaceuticals
CardiovascularRespiratoryPainGastroenterology

ARNA evidence brief

What we can confirm

No verified snapshot fields are available yet.

What it means

The company data is ready for cross-source review; unsupported conclusions remain unknown.

What to watch

Watch the next source-backed data update.
BioSniper AIPage evidence connected

Prepared research question

What matters most for ARNA—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

7.6/10

BioSniper Score

Based on 4 of 6 signals

Market Cap

—

Cash Runway

13.4 mo

Lead Asset

apd418 (Phase 2)

Next Catalyst

—

Financial data as of Dec 31, 2021.

Tracking 5 pipeline candidates for ARENA PHARMACEUTICALS INC.

Run ARENA PHARMACEUTICALS INC through your own thesis

Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.

Your protocol can:

  • Turn available ARENA PHARMACEUTICALS INC facts into screen rules or deeper checks
  • Show cited findings, blockers, and unresolved evidence together
  • Save the logic and rerun it as the company evidence changes
Run a thesis on this company — freeRun a thesis on this company

Score breakdownBased on 4 of 6 signals · derived from public data

Cash Runway3.7

13.4 months

Financial Health9.5

D/E 0.17

Pipeline Maturity8.5

Lead: Phase 3

Pipeline Breadth8.5

5 candidates

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider SignalN/A

No insider transactions in the last 180 days

Runway

Run my thesis on this company

Pipeline

Run my thesis on this company

Financials

Run my thesis on this company

Governance

Run my thesis on this company

Frequently asked questions

What is ARENA PHARMACEUTICALS INC's lead drug candidate?

ARENA PHARMACEUTICALS INC's most advanced tracked candidate is apd418 (Phase 2) for acute heart failure.

Who is the CEO of ARENA PHARMACEUTICALS INC?

Arena Pharmaceuticals is the chief executive officer of ARENA PHARMACEUTICALS INC (ARNA).

What therapeutic areas does ARENA PHARMACEUTICALS INC focus on?

ARENA PHARMACEUTICALS INC develops therapies across Cardiovascular, Respiratory, Pain, Gastroenterology.

925 companies232,681 SEC filings21,419 clinical trials100% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.